Showing results (371-380 of 1,928) with videos related to
Sort By:
Pageof 193
Hematology. American Society of Hematology. Education Program|February 20, 2015
Goals for chronic myeloid leukemia TK inhibitor treatment: how little disease is too much?Michael J MauroHematology. American Society of Hematology. Education Program|February 20, 2015
New insights into treatment of venous thromboembolismStephan MollHematology. American Society of Hematology. Education Program|February 20, 2015
What is the effect of rivaroxaban on routine coagulation tests?Deborah M Siegal, Barbara A KonkleHematology. American Society of Hematology. Education Program|February 20, 2015
Toward optimal therapy for inhibitors in hemophiliaChristine L Kempton, Shannon L MeeksHematology. American Society of Hematology. Education Program|February 20, 2015
Risky business of inhibitors: HLA haplotypes, gene polymorphisms, and immune responsesBirgit M ReipertHematology. American Society of Hematology. Education Program|February 20, 2015
Pregnancy and venous thromboembolism: 'TIPPS' for risk stratificationMarc RodgerHematology. American Society of Hematology. Education Program|February 20, 2015
Reproductive issues in sickle cell diseaseKim Smith-WhitleyHematology. American Society of Hematology. Education Program|February 20, 2015
Does hydroxyurea prevent pulmonary complications of sickle cell disease?Tyler W Buckner, Kenneth I AtagaHematology. American Society of Hematology. Education Program|February 20, 2015
Breakthrough: new guidance for silent cerebral ischemia and infarction in sickle cell diseaseCharles T QuinnHematology. American Society of Hematology. Education Program|February 20, 2015
Replacing bad (F)actors: hemophiliaChristopher B Doering, H Trent SpencerPageof 193